Macrocycle

1 trends tracked about this subject — the full history, oldest to newest below.

↑ Rising Business

Argenx to acquire Unnatural Products in deal worth up to $1.15B

Argenx agrees to acquire Unnatural Products for up to $1.15 billion, betting on AI-guided macrocycle technology to expand oral peptide drug development.

7 sources 7 articles v 5 7h ago

\n \n \n

\n \n \n \n